ClinicalTrials.gg
CompletedNCT04658745Updated Feb 2, 2023

Effects of Theta Burst Stimulation on Modulation of Mirror Illusion-induced Rhythm Suppression in Stroke

An interventional study of Intermittent theta burst stimulation and Mirror Therapy in Stroke and Hemiplegia, sponsored by The Hong Kong Polytechnic University. Completed at 1 site in Hong Kong. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-02-02.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The study aims to test the hypothesis that rTMS in the form of theta burst stimulation (TBS) over the ipsilateral and contralateral motor cortices can modulate mirror illusion-induced rhythm suppression while observing unilateral arm movement in stroke individuals. The investigators further hypothesize that this intervention will lead to the revision of interhemispheric asymmetry. Finally, this study will also explore the longitudinal relationship between rhythm suppression and motor recovery as indicated by motor excitability in the form of MEP. The results of this study will provide significant new information regarding neurophysiological motor relearning mechanisms which could inform the development and evaluation of innovative treatments for individuals with stroke

Read the detailed description

Stroke is the leading cause of physical disability. Facilitating the process of motor relearning would greatly accelerate the rehabilitation of motor functions and elicit positive neuroplasticity of the damaged brain area. Previous research has already explored the feasibility of motor priming techniques embedded in stroke rehabilitation programs using strategies such as non-invasive brain stimulation (NIBS) and mirror therapy (MT). These treatments are usually implemented along with the standardized rehabilitation, sequentially or simultaneously, and have been demonstrated to be more effective than the standardized rehabilitation programs alone.

Mirror neuron, as indicated traditionally by the decrease in the amplitude of Mu rhythm, i.e. a suppression over central electrodes of electroencephalography (EEG), reflects the "seeing" of movement after "perception". Such oscillations are based on neural substrates that are discharged during the observation and execution of a motor act, which is also associated with other human functions, such as imitation, language, etc. The core mirror neuron system (MNS) is thought to be located in the premotor and the primary sensorimotor cortices, indicating that motor learning could be enhanced during action observation and overt movement.

Preliminary research has shown that repetitive Transcranial Magnetic Stimulation (rTMS) can enhance the corticomotor excitability in mirror neurons during both observation of movement (by others) or imagined movement in healthy subjects; in particular, as measured by enhanced motor evoked potentials (MEP). Increases in MEP has also been induced by short-term action observation and mirror visual feedback in stroke survivors. However, it is not yet known if MNS can be activated by TMS in MT following a stroke, and the relationship between mirror neuron activation and clinical improvements in stroke remains unclear.

The investigators have already published preliminary findings in patients with hemiplegic upper extremity, rTMS, and MT. Here, the investigators propose to test the hypothesis that rTMS in the form of theta-burst stimulation (TBS) over the ipsilateral and contralateral motor cortices can modulate mirror illusion-induced rhythm suppression while observing unilateral arm movement in stroke individuals. The investigators further hypothesize that this intervention will lead to the revision of interhemispheric asymmetry. Finally, this study will also explore the longitudinal relationship between rhythm suppression and motor recovery as indicated by motor excitability in the form of MEP. The results of this study will provide significant new information regarding neurophysiological motor relearning mechanisms which could inform the development and evaluation of innovative treatments for individuals with stroke

02

Conditions studied

  • Stroke
  • Hemiplegia

Keywords

  • Stroke
  • upper extremity
  • intermittent theta burst stimulation
  • mirror visual feedback
  • event-related desynchronization
03

In context

Stroke

7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's enrollment of 36 is below the median of 50 across 5,482 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 676 studies on the registry; 254 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. type and location of stroke - ischemic or hemorrhagic, cortical or subcortical, confirmed by medical diagnoses compatible with a unilateral lesion involvement;
  2. Acute stroke patients: stroke with onset of neurological condition ≤3 months, recruited from a local hospital; Chronic stroke patients: stroke with onset of neurological condition from 6 months to 3 years, recruited from self-help organization in the community. The randomization will be pre-stratified into 2 - subacute and chronic stages, and recruit from 2 centers - acute hospital and self-help organizations in the community.
  3. normal or corrected-to-normal visual acuity better than 20/60 (6/18) in the better eye;
  4. right-handed, verified by the Edinburgh Handedness Inventory;
  5. mild to moderately impaired hemiplegic upper extremity functions, with functional levels 5-7 as rated by the Functional Test for the Hemiplegic Upper Extremity - Hong Kong version (FTHUE-HK);
  6. the ability to understand and follow simple verbal instructions;
  7. the ability to participate in a therapy session lasting at least 60 minutes; and
  8. consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

  1. prior neurological or psychiatric disorders;
  2. severe spasticity (Modified Ashworth Scale >3) over hemiplegic upper extremity;
  3. a history of recent Botox injections or acupuncture to the hemiplegic upper extremity within the past three months;
  4. use of central nervous system-active medicine;
  5. any contraindication to TMS, according to the guideline of the Safety of TMS Consensus group, such as the risk of epilepsy, metal implants, and pregnancy;
  6. the presence of unilateral neglect as screened by the Behavioural Inattention Test (CBIT-HK); and
  7. participation in another clinical study elsewhere during recruitment. Informed written consent will be obtained from all patients prior to data collection.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    iTBS over the ipsilesional primary motor cortex plus mirror therapy

    iTBS: iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients. After the iTBS therapy, participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to synchronize with the non-affected hand (illusion on the mirror). The movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.

    Device: Intermittent theta burst stimulation · Behavioral: Mirror Therapy

  • Sham comparator
    Sham iTBS over the ipsilesional primary motor cortex plus mirror therapy

    iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere, but with a sham coil (i.e., sham iTBS). After the sham stimulation, participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to synchronize with the non-affected hand (illusion on the mirror). The movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.

    Behavioral: Mirror Therapy · Device: Sham intermittent theta burst stimulation

  • Sham comparator
    iTBS to the ipsilesional primary motor cortex plus sham mirror therapy

    iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients. After the iTBS therapy, participants will practice the movements with the non-affected hand and try moving the affected arm at the same time, but with a covered mirror (e.g., sham mirror therapy). In the sham mirror therapy condition, the mirror is covered by a cloth and the participant is instructed to move both arms while looking at a cross mark on the covered mirror and imaging the analogous movements of the affected arm. The movement practice will involve 5 table-top tasks (same as mirror therapy) and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.

    Device: Intermittent theta burst stimulation · Behavioral: Sham mirror Therapy

Interventions

  • DeviceIntermittent theta burst stimulation

    iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients, by using a butterfly shape coil.

  • BehavioralMirror Therapy

    Participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to synchronize with the non-affected hand (illusion on the mirror). The movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.

  • DeviceSham intermittent theta burst stimulation

    iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients. However, a sham coil will be used, which is not associated with any stimulation effect on the brain.

  • BehavioralSham mirror Therapy

    In sham mirror therapy, the mirror will be covered. Participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to move the non-affected hand. The participants cannot receive mirror visual feedback of the paretic upper extremity movement during the therapy. Same as mirror therapy, the movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer assessment (FMA)

    A stroke-specific, performance-based impairment index

    Time frame: Baseline

  2. Fugl-Meyer assessment (FMA)

    A stroke-specific, performance-based impairment index

    Time frame: 1 day

  3. Fugl-Meyer assessment (FMA)

    A stroke-specific, performance-based impairment index

    Time frame: 2 weeks

  4. Fugl-Meyer assessment (FMA)

    A stroke-specific, performance-based impairment index

    Time frame: 1-month after the completion of the intervention

  5. Action Research Arm Test (ARAT)

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

    Time frame: Baseline (immediately before the first session)

  6. Action Research Arm Test (ARAT)

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

    Time frame: 1 day

  7. Action Research Arm Test (ARAT)

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

    Time frame: 2 weeks

  8. Action Research Arm Test (ARAT)

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

    Time frame: 1-month after the completion of the intervention

Secondary outcomes

  1. EEG rhythm power

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

    Time frame: Baseline (immediately before the first session)

  2. EEG rhythm power

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

    Time frame: 1 day

  3. EEG rhythm power

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

    Time frame: 2 weeks

  4. EEG rhythm power

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

    Time frame: 1-month after the completion of the intervention

  5. Motor-evoked Potential (MEP)

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex.

    Time frame: Baseline (immediately before the first session)

  6. Motor-evoked Potential (MEP)

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex.

    Time frame: 1 day

  7. Motor-evoked Potential (MEP)

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex.

    Time frame: 2 weeks

  8. Motor-evoked Potential (MEP)

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex

    Time frame: 1-month after the completion of the intervention

  9. Cortical silent period

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

    Time frame: Baseline (immediately before the first session)

  10. Cortical silent period

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

    Time frame: 1 day

  11. Cortical silent period

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

    Time frame: 2 weeks

  12. Cortical silent period

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

    Time frame: 1-month after the completion of the intervention

  13. Ipsilateral silent period

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

    Time frame: Baseline (immediately before the first session)

  14. Ipsilateral silent period

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

    Time frame: 1 day

  15. Ipsilateral silent period

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

    Time frame: 2 weeks

  16. Ipsilateral silent period

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

    Time frame: 1-month after the completion of the intervention

07

Study locations

1 site
  • Kenneth FONG
    Hong Kong, 000000, Hong Kong
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04658745
Collaborators
Queen Mary Hospital, Hong Kong
Responsible party
Sponsor
First posted
Dec 8, 2020
Start date
Sep 23, 2020
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Feb 2, 2023

Study contacts

Kenneth Nai Kuen FONG, PHD
principal investigator · The Hong Kong Polytechnic University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion